Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
573.60
+1.87 (0.33%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Thermo Fisher Revenue
In the year 2023, Thermo Fisher had annual revenue of $42.86B, a decrease of -4.58%. Revenue in the quarter ending December 31, 2023 was $10.89B, a -4.93% decrease year-over-year.
Revenue (ttm)
$42.86B
Revenue Growth
-4.58%
P/S Ratio
5.11
Revenue / Employee
$351,287
Employees
122,000
Market Cap
218.95B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
Dec 31, 2018 | 24.36B | 3.44B | 16.45% |
Dec 31, 2017 | 20.92B | 2.64B | 14.47% |
Dec 31, 2016 | 18.27B | 1.31B | 7.72% |
Dec 31, 2015 | 16.97B | 75.40M | 0.45% |
Dec 31, 2014 | 16.89B | 3.80B | 29.02% |
Dec 31, 2013 | 13.09B | 580.40M | 4.64% |
Dec 31, 2012 | 12.51B | 951.10M | 8.23% |
Dec 31, 2011 | 11.56B | 1.17B | 11.22% |
Dec 31, 2010 | 10.39B | 481.50M | 4.86% |
Dec 31, 2009 | 9.91B | -586.40M | -5.59% |
Dec 31, 2008 | 10.50B | 751.60M | 7.71% |
Dec 31, 2007 | 9.75B | 5.95B | 157.05% |
Dec 31, 2006 | 3.79B | 1.16B | 44.00% |
Dec 31, 2005 | 2.63B | 427.01M | 19.36% |
Dec 31, 2004 | 2.21B | 306.62M | 16.14% |
Dec 31, 2003 | 1.90B | 50.02M | 2.70% |
Dec 28, 2002 | 1.85B | -338.85M | -15.49% |
Dec 29, 2001 | 2.19B | -92.31M | -4.05% |
Dec 30, 2000 | 2.28B | -14.10M | -0.61% |
Jan 1, 2000 | 2.29B | 413.71M | 22.00% |
Jan 2, 1999 | 1.88B | -98.70M | -4.99% |
Jan 3, 1998 | 1.98B | -952.96M | -32.50% |
Dec 28, 1996 | 2.93B | 662.27M | 29.17% |
Dec 28, 1995 | 2.27B | 541.10M | 31.29% |
Dec 28, 1994 | 1.73B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
Pfizer | 58.50B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Abbott Laboratories | 40.11B |
TMO News
- 3 days ago - Thermo Fisher lifts profit forecast as medical equipment demand improves - Reuters
- 3 days ago - Thermo Fisher Scientific to Host Investor Day - Business Wire
- 3 days ago - Thermo Fisher Scientific Reports First Quarter 2024 Results - Business Wire
- 16 days ago - Thermo Fisher Scientific Introduces Animal Origin-Free Formulation to Support Scaling of Cell Therapy Manufacturing - Business Wire
- 18 days ago - Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets - Business Wire
- 19 days ago - Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times - Business Wire
- 25 days ago - Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2024 - Business Wire
- 4 weeks ago - Thermo Fisher Scientific Announces a New In-line Metrology Solution to Improve Battery Safety and Performance - Business Wire